Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (1) Blankenstein, Thomas Prof. Dr. (21) Daniel, Peter Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (12) Kammertöns, Thomas Dr. (5) Kopp, Joachim Dr. (1) Müller, Gerd Dr. (1) Nguyen, Tam Hoai Dr. (1) Rehm, Armin Dr. (4) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (1) (-) Pezzutto, Antonio Prof. Dr. (2) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2004 (1) 2005 (2) (-) 2007 (2) 2010 (1) 2011 (1) (-) 2013 (1) 2015 (2) 2016 (1) 2018 (2) 2019 (2) 2020 (2) 2021 (2) 2022 (12) Biology of Malignant Lymphomas (1) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (1) Genetics, Nephrology, Hypertension, and Vascular Injury (1) Genetics of Metabolic and Reproductive Disorders (2) Mechanism-based Cancer Therapies (1) (-) Microenvironmental Regulation in Autoimmunity and Cancer (1) Molecular Cell Biology and Gene Therapy (2) (-) Molecular Immunology and Gene Therapy (2) Signal Transduction in Development and Cancer (1) 3 Results: Active Filter: Bunse, Mario Dr.Pezzutto, Antonio Prof. Dr.Microenvironmental Regulation in Autoimmunity and CancerMolecular Immunology and Gene Therapy20072013 Sort: Result score Newest to oldest Oldest to newest February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein June 01, 2007 / Canc Gene Ther CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity J. Westermann T. Nguyen-Hoai G. Baldenhofer U.E. Höpken M. Lipp B. Dörken A. Pezzutto
February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
June 01, 2007 / Canc Gene Ther CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity J. Westermann T. Nguyen-Hoai G. Baldenhofer U.E. Höpken M. Lipp B. Dörken A. Pezzutto
